Growth of Breast Biopsy Devices Market to be Impacted by The Paradigm Shift Toward Adoption of Breast Biopsy Robot Systems | Technavio

The report, breast biopsy devices market 2019–2023, has been added to Technavio’s catalog. It provides a comprehensive analysis of the market, including its global and regional market share as well as market segmentation based on product, modality, end-user and geography for the forecast period 2019–2023.

To learn more about the global trends impacting the future of market research: Download Free Sample Report

The report on the breast biopsy devices market 2019–2023 includes:

Breast biopsy devices market analysis and forecast 2018–2023: Features

• Competitive landscape
• Market segmentation
• Market drivers
• Market trends
• Market challenges
• Five forces analysis
• Market landscape
• Market sizing & forecast
• Learning method
• Course type

Breast Biopsy Devices Market 2018–2023: Competitive Landscape

• Vendors covered
• Vendor classification
• Argon Medical Devices Inc.
• Becton, Dickinson and Co.
• Carestream Health Inc.
• Danaher Corp.
• FUJIFILM Holdings Corp.
• General Electric Co.
• Hologic Inc.
• Planmed Oy
• Scion Medical Technologies LLC
• Siemens Healthineers AG

Breast Biopsy Devices Market Landscape 2019–2023: End-user

• Hospitals — Market size and forecast 2018–2023
• ASCs — Market size and forecast 2018–2023
• Breast cancer specialty centers and clinics — Market size and forecast 2018–2023
• Others — Market size and forecast 2018–2023

Breast Biopsy Devices Market Landscape 2019–2023: Product

• Biopsy needles and systems — Market size and forecast 2018–2023
• Biopsy image-guided systems — Market size and forecast 2018–2023
• Others — Market size and forecast 2018–2023

Breast Biopsy Devices Market Landscape 2019–2023: Modality

• Stereotactic X-ray guided breast biopsy — Market size and forecast 2018–2023
• Ultrasound-guided breast biopsy — Market size and forecast 2018–2023
• MRI-guided breast biopsy — Market size and forecast 2018–2023

Growing prevalence of breast cancer cases will drive the breast biopsy devices market

Breast cancer is one of the commonest forms of cancer, which is majorly observed in the female population worldwide. The geriatric female population is more likely to develop breast cancer. However, even young women have a higher risk of developing breast cancer if they have a genetic propensity for ovarian and breast cancer or if there is a mutation in their BRCAI and BRCA2 gene. Thus, such factors are thereby expected to drive the growth of the breast biopsy devices market.

Paradigm shift toward adoption of breast biopsy robot systems — An emerging trend in the breast biopsy devices market

The growing adoption of minimally invasive procedures for breast cancer screening has increased the demand for technologically advanced breast biopsy devices. The demand for accurate and efficient surgical procedures has increased the demand for robotic platforms, surgical navigation systems, and artificial intelligence. The incorporation of robotics can reduce surgical and other complications associated with these procedures. These devices will also help in performing breast biopsies more precisely and thereby, improving the surgical outcomes during the breast biopsy process.

Other Key Topics Covered in the Report are:

MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018–2023

Get Full Report: https://www.technavio.com/report/breast-biopsy-devices-market-industry-analysis